[HTML][HTML] Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: systematic review and …
KM Souza, G Carrasco, R Rojas-Cortés… - Plos one, 2023 - journals.plos.org
Objective To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta …
KM Souza, G Carrasco, R Rojas-Cortés… - PLoS …, 2023 - ui.adsabs.harvard.edu
Objective To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta …
KM Souza, G Carrasco, R Rojas-Cortés, M Barbosa… - Plos one, 2023 - europepmc.org
Objective To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta …
KM Souza, G Carrasco, R Rojas-Cortés… - medRxiv, 2023 - medrxiv.org
Objective To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
[PDF][PDF] Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta …
KM Souza, G Carrasco, R Rojas-Cortés… - PLoS ONE, 2023 - researchgate.net
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19
and at high risk of hospita Page 1 RESEARCH ARTICLE Effectiveness of nirmatrelvir-ritonavir …
and at high risk of hospita Page 1 RESEARCH ARTICLE Effectiveness of nirmatrelvir-ritonavir …
[PDF][PDF] Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta …
KM Souza, G Carrasco, R Rojas-Cortés… - PLoS ONE, 2023 - scienceopen.com
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19
and at high risk of hospita Page 1 RESEARCH ARTICLE Effectiveness of nirmatrelvir-ritonavir …
and at high risk of hospita Page 1 RESEARCH ARTICLE Effectiveness of nirmatrelvir-ritonavir …
[HTML][HTML] Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and …
KM Souza, G Carrasco, R Rojas-Cortés, MM Barbosa… - PLOS …, 2023 - ncbi.nlm.nih.gov
Objective To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta …
KM Souza, G Carrasco, R Rojas-Cortés… - PloS …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: systematic review and meta …
KM Souza, G Carrasco, R Rojas-Cortés, MM Barbosa… - 2023 - cabidigitallibrary.org
Objective: To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta …
KM Souza, G Carrasco, R Rojas-Cortés… - PLoS …, 2023 - search.ebscohost.com
Objective: To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …
with mild to moderate COVID-19 who are at higher risk of developing severe illness, through …